Shoulder Innovations, INC 8-K filings

Shoulder Innovations, Inc. announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026, to lead commercial strategy and execution.

Shoulder Innovations, Inc. announced the closing of up to $50 million in new credit facilities with Stifel Bank, including a $15 million term loan to refinance existing debt and a $30 million revolving line of credit for working capital.

Shoulder Innovations, Inc. successfully concluded its 2026 Annual Meeting of Stockholders, confirming the election of two directors and the ratification of its independent auditor.

Shoulder Innovations reported a 65% year-over-year increase in first-quarter net revenue to $16.7 million and raised its full-year 2026 revenue guidance.

Shoulder Innovations announces the full commercial launch of its InSet I-135RFX Humeral Stem, expanding its product line for all primary, revision, and fracture total shoulder arthroplasty procedures.

Shoulder Innovations, Inc. has entered into a 10-year lease agreement for a new 15,200 sq ft corporate headquarters expected to be completed in Q4 2027.

Shoulder Innovations, Inc. announced the appointment of medical technology veteran Drew Hykes to its Board of Directors, replacing Geoff Pardo.

Shoulder Innovations, Inc. announced a strategic partnership with Interventional Systems to introduce a transformative shoulder-specific micro-robotic solution for arthroplasty.

Shoulder Innovations, Inc. reported robust third-quarter 2025 financial results, with revenue surging 58% year-over-year, leading to an increased full-year revenue guidance.

Shoulder Innovations announced strong second quarter 2025 financial results, with net revenue increasing 33% year-over-year, alongside significant financing activities.

Shoulder Innovations, Inc. has amended its corporate charter and bylaws following its initial public offering, implementing standard governance changes for a public company.